TopFunds

Universal Health Services

NYSE: UHS

Stock price

176.39 USD

(+0%) TODAY

Health Care FacilitiesMedical - Care Facilities
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
6.8
7.1
7.8
8.3
9.1
11
11.8
9.1
10.2
16.8
23.1
13.1%
02Free cash flow per share
1.1
1.4
6
5.6
8.7
19
0.3
3.5
7.5
16.5
13.2
28.5%
03Dividends per share
0.4
0.4
0.4
0.4
0.6
0.2
0.8
0.8
0.8
0.8
0.8
7.2%
04Dividends payout, %
5.8%
5.5%
5.1%
4.8%
6.5%
1.8%
6.7%
8.7%
7.7%
4.7%
3.4%
(5.1)%
PROFIT AND LOSS STATEMENT
05Revenue
$ 9,044
$ 9,766
$ 10,410
$ 10,772
$ 11,378
$ 11,559
$ 12,642
$ 13,399
$ 14,282
$ 15,828
$ 17,365
6.7%
06% Change
-
8%
6.6%
3.5%
5.6%
1.6%
9.4%
6%
6.6%
10.8%
9.7%
6.7%
07Cost of revenue
(974.1)
(1,031)
(1,105)
(1,169)
(1,251)
(1,288)
(1,427)
(1,474)
(1,533)
(1,588)
(1,659)
5.5%
08Gross profit
8,069
8,735
9,305
9,604
10,127
10,271
11,215
11,925
12,749
14,240
15,706
6.9%
09% Margin
89.2%
89.4%
89.4%
89.2%
89%
88.9%
88.7%
89%
89.3%
90%
90.5%
89.3% A
10Operating expenses
(6,810)
(7,454)
(8,025)
(8,428)
(8,911)
(8,912)
(9,852)
(10,922)
(11,574)
(12,558)
(13,712)
7.3%
11% of Revenue
(75.3)%
(76.3)%
(77.1)%
(78.2)%
(78.3)%
(77.1)%
(77.9)%
(81.5)%
(81)%
(79.3)%
(79)%
(78.3)% A
12Operating Income
1,259
1,281
1,280
1,175
1,216
1,358
1,363
1,004
1,175
1,682
1,994
4.7%
13Income tax expense
(395.2)
(409.2)
(363.7)
(236.6)
(238.8)
(299.3)
(305.7)
(209.3)
(221.1)
(334.8)
(461)
1.6%
14Net Income
680.5
702.4
752.3
779.7
814.9
944
991.6
675.6
717.8
1,142
1,489
8.1%
15% Margin
7.5%
7.2%
7.2%
7.2%
7.2%
8.2%
7.8%
5%
5%
7.2%
8.6%
7.1% A
16Shares Outstanding
100,694
98,380
96,325
93,750
89,040
85,587
83,692
73,832
70,125
67,896
64,462
(4.4)%
17EPS Basic
6.9
7.2
7.9
8.4
9.2
11.1
12
9.2
10.4
17.2
23.4
13%
18EPS Diluted
6.8
7.1
7.8
8.3
9.1
11
11.8
9.1
10.2
16.8
23.1
13.1%
19EBITDA
1,641
1,682
1,717
1,635
1,720
1,869
1,910
1,575
1,715
2,265
2,743
5.3%
% Margin
18.2%
17.2%
16.5%
15.2%
15.1%
16.2%
15.1%
11.8%
12%
14.3%
15.8%
15.2% A
20Net Interest Income (expense)
(103.3)
(116.6)
(142.8)
(155)
(162.7)
(106.3)
(83.7)
(126.9)
(206.7)
(186.1)
(156.1)
4.2%
21Net Debt / EBITDA
2.1
2.4
2.3
2.4
2.5
1.6
2.3
3.3
3.1
2.1
2
2.4 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
61.2
33.7
74.4
105.2
61.3
1,225
115.3
102.8
119.4
126
137.8
8.5%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
1,302
1,440
1,501
1,510
1,561
1,729
1,747
2,018
2,238
2,178
2,602
7.2%
25Other current assets
238.6
82.7
86.5
174.5
133.9
138
194.8
198.3
236.7
291.6
435.6
6.2%
26Inventory
116
125.4
136.2
148.2
159.9
190.4
206.8
218.5
217
220.9
232.1
7.2%
27Total Current Assets
1,718
1,681
1,798
1,938
1,916
3,282
2,264
2,537
2,811
2,816
3,408
7.1%
Non-Current Assets
28Net property, plant & equipment
3,836
4,331
4,572
4,848
5,343
5,710
6,242
6,373
6,559
6,991
7,382
6.8%
29Long-term investments
-
-
-
-
-
-
-
-
-
318.7
346.2
-
30Other non-current assets
4,061
4,306
4,392
4,480
4,409
4,485
4,588
4,584
4,598
4,344
4,821
1.7%
31Total Non-Current Assets
7,897
8,636
8,964
9,328
9,752
10,195
10,830
10,957
11,156
11,654
12,549
4.7%
Total Assets
9,615
10,318
10,762
11,266
11,668
13,477
13,094
13,494
13,968
14,470
15,957
5.2%
LIABILITIES
Current Liabilities
32Accounts payable
366.2
439.7
442
445.7
447
570.5
658.9
636.6
614
632
750.1
7.4%
33Short-term debt
62.7
105.9
545.6
63.4
144
391.8
112.9
149.2
198.3
114.7
821.4
29.3%
34Other current liabilities
671.4
771.8
860.4
939.6
972.4
1,519
1,212
1,129
1,201
1,464
1,668
9.5%
35Total Current Liabilities
1,100
1,317
1,848
1,449
1,563
2,481
1,984
1,914
2,013
2,210
3,240
11.4%
Non-Current Liabilities
36Long-term debt
3,369
4,030
3,494
3,935
4,167
3,803
4,447
5,122
5,168
4,841
4,686
3.4%
37Other non-current liabilities
594.7
363.3
361.3
411.5
355
786.7
464.8
487.7
584
655.8
622.3
0.5%
38Total Non-Current Liabilities
3,963
4,394
3,856
4,347
4,522
4,589
4,911
5,610
5,752
5,497
5,308
3%
39Total Liabilities
5,064
5,711
5,704
5,795
6,085
7,070
6,895
7,524
7,766
7,707
8,548
5.4%
SHAREHOLDERS` EQUITY
40Common stock
1
1
0.9
0.9
0.9
0.9
0.8
0.7
0.7
0.7
0.6
(4.6)%
41Retained earnings / (deficit)
4,567
4,891
4,981
5,384
5,471
6,268
6,059
5,930
6,799
7,372
7,993
5.8%
42Accumulated other comprehensive income / (loss)
(317.9)
(359)
7.2
4.2
31.9
48.1
30.3
(9.7)
(650.6)
(706.5)
(717.6)
8.5%
43Noncontrolling interests
302
73.7
68.6
80.8
79.1
89.4
108.5
49.5
52.9
96.6
133.6
(7.8)%
44Total shareholders' equity
4,552
4,607
5,058
5,470
5,583
6,407
6,198
5,970
6,202
6,763
7,409
5%
45Total Liabilities and shareholders' Equity
9,615
10,318
10,762
11,266
11,668
13,477
13,094
13,494
13,968
14,470
15,957
5.2%
46Total Debt
3,431
4,136
4,040
3,999
4,311
4,194
4,559
5,271
5,367
4,955
5,507
4.8%
47Net Debt
3,370
4,102
3,966
3,893
4,249
2,970
4,444
5,169
5,247
4,829
5,369
4.8%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
680.5
702.4
752.3
779.7
814.9
944
991.6
675.6
717.8
1,142
1,489
8.1%
49Depreciation & amortization
398.6
416.6
447.9
453.1
490.4
510.5
533.2
581.9
568
584.8
618.7
4.5%
50Share-based compensation expense
40
48.1
56.7
66.6
69.4
65.8
73.7
85.4
87.7
99.3
95.7
9.1%
51Changes in working capital and other assets
(98.2)
121.3
(74.3)
41.5
63.8
839.9
(714.8)
(346.8)
(105.8)
240.8
(338.8)
13.2%
52Net cash flows from operating activities
1,021
1,289
1,183
1,341
1,439
2,360
883.7
996
1,268
2,067
1,864
6.2%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(913)
(1,155)
(609.4)
(811.7)
(663.5)
(734.2)
(855.7)
(734)
(743.1)
(943.8)
(1,015)
1.1%
54Purchases of investments / marketable securities
-
-
(8)
(15.3)
(34.3)
(24.4)
(1.4)
-
-
-
(52.2)
-
55Proceeds from maturities of marketable securities
-
-
-
-
34.3
-
-
94.9
-
-
-
-
56Other investing activities
0.1
(32)
(7)
13.6
(24.9)
(43.9)
(57.4)
(8.2)
(20.2)
32.7
(3.3)
-
57Net cash flows from investing activities
(912.9)
(1,187)
(624.4)
(813.4)
(688.4)
(802.6)
(914.5)
(647.3)
(763.3)
(911.1)
(1,071)
1.6%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(201.3)
(343.9)
(354.1)
(387.2)
(759.7)
(194.4)
(1,208)
(818.8)
(533.7)
(655.7)
(951.2)
16.8%
59Dividends paid, net
(39.5)
(38.9)
(38.2)
(37.3)
(53)
(17.3)
(65.9)
(58.4)
(55.5)
(53.3)
(51.3)
2.6%
60Debt issuance (repayments), net
179
711.6
(102)
(53)
(17.9)
(161)
217.1
616
99.6
(429.8)
241.7
3.1%
61Other financing activities
(15.4)
(454.8)
(24.8)
(14.6)
(14.4)
(12.1)
(12.7)
(57.1)
(4.4)
(6.1)
11.1
-
62Net cash flows from financing activities
(77.2)
(125.9)
(519.2)
(492.2)
(845)
(384.9)
(1,069)
(318.4)
(493.9)
(1,145)
(749.7)
25.5%
63Increase (decrease) in cash and cash equivalents
29.2
(27.5)
40.7
32.4
(94)
1,174
(1,100)
21.9
13.6
10.3
46.6
4.8%
64Cash and equivalents, ending balance
61.2
33.7
74.4
199.7
105.7
1,279
178.9
200.8
214.5
224.8
271.3
16.1%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
107.9
133.3
573.2
529.2
775
1,626
28
262
524.7
1,123
849.2
22.9%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
2025202420232022202120202019201820172016

Universal Health Services (UHS) financial statements and performance

Explore Universal Health Services (UHS) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.